The signs of brain cancer may be due to hydrocephalus, which occurs when the tumor blocks the flow of cerebrospinal fluid and causes a build-up in the ventricles. The symptoms or signs also may caused by edema, a condition when a buildup of fluid around the tumor.

Temporal lobe

Once the tumor onset temporal lobe, occasional speech difficulties may happen. Fits may cause strange sensations, short term memory lossan, intense familiarity (deja vu), strange smells, feeling of fear or blackouts.

Frontal lobe

Changes in personality and intellect. Weakness of one side of the body. Loss of smell, swearing or behaving in a way that you normally, wouldn’toccasional speech difficulties.

Cerebellum

Lack of co-ordination affecting speech and walking, unsteadiness, uncontrolled movement of the eyes, neck stiffness, dizziness, and vomiting.

Parietal lobe

Difficulty in organising certain movements. Have problem in understanding or expressing problems and words with writing or reading. Wakness or numbness on one side of the body and loss of feeling in part of the body.

Occipital lobe

Having loss of vision or sight problems on one side. The patient may not notice this at first.

Brain stem

Facial weakness, one sided smile or drooping eyelid. Unsteadiness and uncoordinated walk. Double vision. Rarely, headache or vomiting just after waking, difficulty in swallowing and speaking.

The signs of brain cancer above may be caused by other conditions. If you have any of the symptoms described it is urgent to see the doctor.

Brain cancer are rare, because of this rarity and despite their increasing rate of diagnosis, experts often don’t check patients right off the bat for brain tumors and may point to other conditions. A brain tumour signs may the body process, that is controlled by that part of the brain or the part of the body This means that brain tumours can cause a very wide range of symptoms.

Brain cancer can may also cause problems with thinking, speaking, remembering, concentrating and personality changes. Common signs and symptoms caused by brain tumors may include:

1. Seizures

Seizures are a common symptom of a brain cancer. About one-third of people diagnosed with a brain cancer have a seizure. Seizures are caused by a disruption in the normal flow of electricity in the brain. Those sudden bursts of electricity may cause unusual sensations, loss of consciousness and convulsions.

2. Problems with eyes

This is particularly important if the sight seems to be failing and glasses are not helping. Other problems floating shapes, tunnel vision, include blurred vision, or a loss of vision that comes and goes. Sometimes opticians pick up these problems

3. Headaches

Headaches are not usually the initial symptom of a brain cancer or the only one experienced. Up to half of people with brain tumors suffer from headaches, but they are much more likely to be related to another benign condition. Brain cancer headaches are often accompanied by other symptoms.

Frequent headaches should not be ignored regardless of accompanying symptoms, especially those that worsen with bending over, sneezing or couching.

4. Mental or Personality Changes

These changes can be caused by the disease itself, by increased pressure within the skull caused by involvement of the parts of the brain or by the presence of the tumor that control personality.

brain cancer symptoms may range from problems with communication, memory, speech, or concentration changes to severe intellectual problems and confusion. Changes in behavior, temperament and personality may also happen.

1. Joint and bone pain

Pain in bones and joints is another common symptom of leukemia. This pain is usually a result of the bone marrow being overcrowded and “full.”

2. Anemia

They lack enough red blood cells to carry oxygen through the body, which causes a condition called anemia. Children with anemia may look pale, feel weak and tired and bleed and bruise easily. Also often have fewer than normal healthy platelets and red blood cells.

3. Recurrent infections

Children may experience repetitive viral or bacterial infections. They often have symptoms of infection such as fever, runny nose and cough. Although children with leukemia may have a high number of white blood cells, these white blood cells are immature and don’t fight infection.

4. Dyspnea or difficulty breathing

With T-cell acute lymphocytic leukemia, leukemia cells tend to clump together around the thymus gland. This mass of cells present in the middle of the chest can cause pain and difficulty breathing. Wheezing, coughing or painful breathing requires immediate medical attention.

5. Swollen lymph nodes

Lymph nodes under the arms, in the groin, chest and neck may become swollen when leukemia cells collect in the nodes. Lymph nodes are small bean-shaped structures that filter the blood.

6. Abdominal distress

Abdominal pain also may be a symptom. Leukemia cells can collect in the kidney, liver and spleen, enlarging these organs. Pain in the abdomen may cause a loss of appetite and weight.

The only way to know for sure if the skin is the growth of cancer is a biopsy, he said. This involves removing a small piece of skin and having a pathologist look at it under a microscope in medical laboratory. The biopsy does not remove the tumor is removed only at the top.

Some times the skin to heal after the biopsy because the cancer grows. This does not mean that there is cancer it means that cancer is now covered with a blanket of skin. If the cancer is not completely removed can go deep into the skin and cause severe damage.

Signs and symptoms

Patients present with a shiny, pearly nodule. However, superficial basal-cell cancer can present as a red patch like eczema. Infiltrative or morpheaform basal-cell cancers can present as a skin thickening or scar tissue. It is often difficult to distinguish basal-cell cancer from acne scar, actinic elastosis, and recent cryodestruction inflammation.

The Major Cause

In a few cases, contact with arsenic, exposure to radiation, open sores that resist healing, chronic inflammatory skin conditions, and complications of burns, scars, infections, vaccinations, or even tattoos are contributing factors.

Almost all basal cell carcinomas occur on parts of the body excessively exposed to the sun . On rare occasions, however, tumors develop on unexposed areas.

Prognosis

Prognosis is excellent if the appropriate method of treatment is used in early primary basal-cell cancers. Recurrent cancers are much harder to cure, with a higher recurrent rate with any methods of treatment. Although basal-cell carcinoma rarely metastasizes, it grows locally with invasion and destruction of local tissues.

The cancer can impinge on vital structures like nerves and result in loss of sensation or loss of function or rarely death. The vast majority of cases can be successfully treated before serious complications occur. The recurrence rate for the above treatment options ranges from 50 percent to 1 percent or less.

Prevention

The best way to prevent skin cancer is to reduce your exposure to sunlight. Ultraviolet light is most intense at midday, so try to avoid sun exposure during these hours. Protect the skin by wearing hats, long-sleeved shirts, long skirts, or pants.

Use sunscreen:

• Look for sunscreens that block both UVA and UVB light.
• Apply high-quality sunscreens with SPF ratings of at least 15.
• Apply sunscreen at least 30 minutes before going outside.

Overexpose ultraviolet (UV) radiation from the sun or tanning salons is the common cause of skin cancer. It causes 80% of skin cancer cases. UV rays can damage DNA, the genetic material that makes up genes. Genes control the overall health of skin cells.

If the genetic damage is severe, a normal skin cell may begin to grow in the uncontrolled, disorderly way of cancer cells.

There are two types of ultraviolet (UV) rays,

• Ultraviolet A (UVA) wavelengths 320 to 400 (nm) in length.
• Ultraviolet B (UVB) wavelengths are 280 to 320 nm in length.

Researchers once thought that excessive exposure to UVB rays was the main cause of skin cancer. Now they think that UVA also takes apart. That’s why it is important to use a sun block product that protects against both UVA and UVB rays.

In most cases, UV rays react with a substance called melanin that is found in the skin. This is the first defense against the sun, as it is the melanin that absorbs the dangerous this cause of skin cancer rays that can do serious skin damage. The sunburn develops when the amount of UV damage exceeds the protection that the skin’s melanin can provide.

While a small amount of exposure to sunlight is healthy, while overexpose can be dangerous and may cause of skin cancer. Measures should be taken to prevent overexposure to sunlight in order to maintain the risks of cancers, premature aging of the skin, and other bad effects.

Skin cancer my form once the immune system failing or not functioning properly. The immunotherapy is focused to enhance and repair the human body’s immune responses. Nowadays the technique such as interferon is use with or without other common cancer treatment techniques such as chemotherapy, surgery and radiotherapy.

The aim of immunotherapy treatment for skin cancer:

• Avoided skin cancer cells from metastasized to other organs.
• Make cancer cells more susceptible to destruction by body’s immune system.
• Stop, suppress or control the processes that allow cancer growth.
• Advance the protecting power of body’s natural immune system cells
• Enhance the body’s ability to destroyed by other forms of cancer treatment, such as chemotherapy or radiation and to replace normal cells damaged
• Reverse or block the process that changes a pre-cancerous cell into a cancerous cell

Drug in immunotherapy treatment for skin cancer

Aldara induces the formation of interferon in the skin. This is the first of a class of drugs called immune modulators. This drug Interferon has antiviral, anti-tumor, and anti-proliferative activities. Aldara has been used for years to treat skin cancer.

Experts have developed several types of immunotherapy to treat skin cancer. These therapies are classified as “passive” when substances that the body produces are synthetically created in a laboratory and “active” when they stimulate the patient’s own immune system to fight the cancer.

Immunotherapy treatment for skin cancer can be directly applied to the skin or systemic by injection, infusion, or taken pill.

Skin cancer can develop of all races with different skin tones. The common symptom or sign of skin cancer is a change in the physical appearance of the skin. The change may affect in color or skin structure and shape such as a sore or a new growth that will not heal.

Other skin cancer symptoms:

• A small lump, kind of mole or spot that is waxy, shiny, smooth in texture and pale in color.
• A spot or sore that do not heal and that bleeds or become crusty.
• Scaly and rough patches on the skin.
• Flat scaly areas of the skin that are brown or red.
• Any unusual new growth on the skin that is suspicious. These growths are usually painless, but can be painful.

The skin cancer symptoms above did not include the signs of melanoma, a highly dangerous and deadly type of skin cancer.

It is strongly suggested to have a regularly clinical skin exam by the expert. If someone suspect that a mole lump, or spot may be suspicious of skin cancer, see your doctor as soon as possible. It is also recommended to perform regular skin self-check to look for unusual skin changes.

Robert H. Vonderheide, MD, DPhil, an associate professor of medicine in the division of hematology/oncology and the Abramson Family Cancer Research Institute, University of Pennsylvania, said that the novel treatment works by destroying the ”scaffolding” that surround the cancer cells.

”Instead of binding to pancreatic cancer, this antibody binds to a molecule in the immune system, and that is CD40,” Vonderheide said. He also tells that the immune system next is activated, allowing it to attack the so-called scaffolding around the cancer cells. The scaffolding is destroyed and the tumor falls apart.

Compared to conventional treatments, the new pancreatic cancer treatment extended overall survival by nearly two months. Progression-free survival, the length of time during which the tumor did not grow, was more than three months longer.

Pancreatic Cancer Treatment: Study Details

The scientists studied the new immune therapy for pancreatic cancer treatment in people and in mice. 21 patients with the most common type of pancreatic cancer, ductal adenocarcinoma, were given the combination of gemcitabine with the new antibody treatment, known as CP-870,893.

The antibody infusion, given once a month, was added to the routine gemcitabine treatment. Side effects included chills and fevers and usually went away within 24 hours. The new treatment was found to be well tolerated in this phase 1 trial, Vonderheide says.

“We are reporting that five patients who received the antibody went on to tumor regression that was at least 30% or more,” Vonderheide says. After two cycles, the patients were scanned to evaluate the tumors. That 30% is considered the cutoff for an acceptable response, he says.

The median overall survival time was 7.4 months. The median time for progression-free survival was 5.6 months. In comparison, gemcitabine alone produces a median overall survival time of 5.7 months and a median progression-free survival of 2.3 months.

Source: WebMD

Melanoma is the most common kind of cancer for women in their 20s and the most dangerous type of skin cancer. Every year, more than 10,400 people are diagnosed with it in the UK and 2,000 die.

The drug prolongs lives by an average of four months in patients whose have skin cancer that has metastasis to other tissue. Some patients are survives after having the treatment for four years long.

An oncologist at The Christie Hospital NHS Trust, Dr Paul Lorigan, said it ‘appears to work on everyone’s immune system in the same way’. This means, Lorigan added, that ‘most patients in the UK with advanced melanoma could be suitable for treatment if it is approved, and some will have their lives extended significantly’.

Base on the results in the New England Journal of Medicine, patients’ survives were extended by an average of ten months, compared with six months for patients not on the drug.

‘It changes the way the immune system works so the immune system attacks the cancer,’ Dr James Larkin, another trial co-ordinator, a consultant medical oncologist at the Royal Marsden NHS Foundation Trust, said. He also said it was the first drug since the 1970s to show any increase in survival for patients with the advanced disease.

Although melanoma can be treated if caught early, just five per cent of patients who develop metastatic disease are still alive five years after diagnosis.

Acute leukemia is a disease that results in the accumulation of functionless, immature cells in the blood and marrow. Often the marrow can no longer develop enough normal platelets, white and red blood cells.

Commonly the disease is treated with pharmaceutical medications, typically combined into a multi-drug chemotherapy regimen. In some cases, a bone marrow transplant is useful.

The following systems are typically included in a treatment plan for acute leukemia.

1. Chemotherapy

The main purpose of acute leukemia chemotherapy treatment is to kill the abnormal cell in the bone marrow and blood and gives change to the remaining normal cells to grow and produce normal blood cells again. Chemotherapy is the most effective treatment for acute leukemia, because the bone marrow is present in many bones throughout the body.

2. Transfusions

Patients with chemotherapy, often require transfusions of platelets and red blood cells. It because in chemotherapy process, blood counts frequently drop to low levels before normal blood cells begin to grow again.

3. Venous catheter

A surgeon who does the acute leukemia treatment will typically place a long-term central venous catheter under the collarbone or in the neck in a vein. The catheter is tunneled from the vein under the skin, exiting in the middle of the chest.

The tubing provides access for blood sampling, the administration of chemotherapy and antibiotics and blood transfusions.

4. Bone marrow transplant

Bone marrow transplantation is often recommended to become the treatment of acute leukemia to patients who have a subtype of acute leukemia or if the leukemia recurs after initial treatment. The transplant can use cells from another person the patient’s own cells or.

Melanoma is the type of skin cancer, the deadly one. This cancer occurs in human pigment cells. Every year, at the United Kingdom there are over 10,000 patients which diagnosed with this type of cancer.

Unlike other types of cancer, the patient number with melanoma continues to rise from year to year. Melanoma can be cured if treated early as possible, but if it’s too late and the cancer already spread to other organs, the chance for recovery is very low.

Researchers at the University of East Anglia may have found a drug that can inhibit the harmful effects of melanoma. Scientists have tested hundreds of the compounds and its influence on the formation of pigment cells in the tadpole.

Along with the Children’s Hospital in Boston, they prove that leflunomide, a drug commonly used for rheumatoid arthritis, can inhibit tumor growth in mice. The most convincing is when leflunomide in combination with new therapies for melanoma, PLX4720, both are able to stop almost all tumors growth.

“This is a really exciting discovery… making use of an existing drug specifically to target melanoma… Deaths from melanoma skin cancer are increasing and there is a desperate need for new, more effective treatments. We are very optimistic that this research will lead to novel treatments for melanoma tumors which, working alongside other therapies, will help to stop them progressing.” Dr. Grant Wheeler, of University of East Anglia’s School of Biological Science, said.

The next step for leflunomide is clinical trials for its use as a melanoma treatment, a process that should be faster than usual since leflunomide is already an approved drug for arthritis. There could be a new treatment for melanoma within five years.

Dr. Eva Negri, a senior researcher of the “Mario Negri” Institute of Pharmacological Research in Milan, said: “Smoking has long been considered a risk factor for stomach and throat cancers. But these latest findings offer a “better quantification” of the risks.” What’s more, they suggest that the risks remain higher than average for some time after smokers quit.

Aggregating the results of 33 other past studies, the researchers had compared a relatively small group of patients with either esophagus or gastric cardia tumors against a cancer-free group. The researchers found that current smokers were more than twice as likely as nonsmokers to develop cancer, either in gastric cardia, a part of the stomach, or in their esophagus.

In recent decades, rates of the cancers have been rising in the U.S. and Europe. The two cancers, both known as adenocarcinomas, are relatively uncommon in Western countries. Rates elsewhere are much higher, especially in less developed countries.

And while that risk declined after people stopped smoking, it was still 62 percent higher in former smokers than in lifelong non-smokers. In some studies, the extra risk of esophagus cancer persisted up to 30 years after people had quit.